TECHBIO-TECHNE Corp

Nasdaq bio-techne.com


$ 71.50 $ -0.88 (-1.22 %)    

Friday, 06-Sep-2024 15:59:59 EDT
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 71.49
$ 71.45 x 100
-- x --
-- - --
$ 51.55 - $ 85.48
734,814
na
11.34B
$ 1.04
$ 67.45
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-22-2024 06-30-2024 10-K
2 05-06-2024 03-31-2024 10-Q
3 02-07-2024 12-31-2023 10-Q
4 11-07-2023 09-30-2023 10-Q
5 08-23-2023 06-30-2023 10-K
6 05-08-2023 03-31-2023 10-Q
7 02-07-2023 12-31-2022 10-Q
8 11-07-2022 09-30-2022 10-Q
9 08-24-2022 06-30-2022 10-K
10 05-09-2022 03-31-2022 10-Q
11 02-07-2022 12-31-2021 10-Q
12 11-08-2021 09-30-2021 10-Q
13 08-25-2021 06-30-2021 10-K
14 05-07-2021 03-31-2021 10-Q
15 02-08-2021 12-31-2020 10-Q
16 11-09-2020 09-30-2020 10-Q
17 08-26-2020 06-30-2020 10-K
18 05-11-2020 03-31-2020 10-Q
19 02-06-2020 12-31-2019 10-Q
20 11-06-2019 09-30-2019 10-Q
21 08-28-2019 06-30-2019 10-K
22 05-07-2019 03-31-2019 10-Q
23 02-07-2019 12-31-2018 10-Q
24 11-07-2018 09-30-2018 10-Q
25 08-27-2018 06-30-2018 10-K
26 05-09-2018 03-31-2018 10-Q
27 02-08-2018 12-31-2017 10-Q
28 11-09-2017 09-30-2017 10-Q
29 09-07-2017 06-30-2017 10-K
30 05-10-2017 03-31-2017 10-Q
31 02-09-2017 12-31-2016 10-Q
32 11-09-2016 09-30-2016 10-Q
33 08-29-2016 06-30-2016 10-K
34 05-10-2016 03-31-2016 10-Q
35 02-09-2016 12-31-2015 10-Q
36 11-09-2015 09-30-2015 10-Q
37 08-31-2015 06-30-2015 10-K
38 05-11-2015 03-31-2015 10-Q
39 02-09-2015 12-31-2014 10-Q
40 11-10-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 benchmark-reiterates-buy-on-bio-techne-maintains-95-price-target

Benchmark analyst Robert Wasserman reiterates Bio-Techne (NASDAQ:TECH) with a Buy and maintains $95 price target.

 warner-bros-airbnb-and-monster-beverage-are-among-top-10-large-cap-losers-last-week-aug-4-aug-10-are-the-others-in-your-portfolio

These 10 stocks had the biggest drop last week, with McKesson Corporation, BIO-TECHNE Corp, and Warner Bros. Discovery, Inc. be...

 rbc-capital-maintains-sector-perform-on-bio-techne-lowers-price-target-to-70

RBC Capital analyst Conor McNamara maintains Bio-Techne (NASDAQ:TECH) with a Sector Perform and lowers the price target from...

 baird-maintains-outperform-on-bio-techne-raises-price-target-to-82

Baird analyst Catherine Schulte maintains Bio-Techne (NASDAQ:TECH) with a Outperform and raises the price target from $81 to...

 bio-techne-q4-2024-adj-eps-049-inline-sales-306098m-miss-306491m-estimate

Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.49 per share which met the analyst consensus estimate. The company ...

 citigroup-downgrades-bio-techne-to-neutral-announces-85-price-target

Citigroup analyst Patrick Donnelly downgrades Bio-Techne (NASDAQ:TECH) from Buy to Neutral and announces $85 price target.

 molecular-instruments-announced-the-patents-court-of-england-and-wales-has-ordered-that-two-patents-owned-by-advanced-cell-diagnostics-a-bio-techne-company-both-be-revoked-advanced-cell-diagnostics-infringement-claims-against-molecular-instruments-are-dismissed-and-advanced-cell-diagnostics-make-a-costs-payment-of-172m-to-molecular-instruments

Molecular Instruments, Inc. announced that the Patents Court of the High Court of England and Wales has ordered: (1) that two p...

 which-large-cap-stocks-are-winning-this-earnings-season-15-stocks-to-watch-april-28-may-4-2024

Last week's top performers included Carvana, Pinterest, Moderna and JD.Com.

 benchmark-reiterates-buy-on-bio-techne-maintains-95-price-target

Benchmark analyst Robert Wasserman reiterates Bio-Techne (NASDAQ:TECH) with a Buy and maintains $95 price target.

 baird-maintains-outperform-on-bio-techne-raises-price-target-to-81

Baird analyst Catherine Schulte maintains Bio-Techne (NASDAQ:TECH) with a Outperform and raises the price target from $73 to...

 bio-techne-q3-adj-048-beats-045-estimate-sales-30343m-beat-29219m-estimate

Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.45 by 6...

Core News & Articles

Under this agreement, Thermo Fisher, through the European arm of its Fisher Scientific Channel, will distribute Bio-Techne'...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION